SeamlessMD Podcast - Episode 39 - Rush Study Review: Value of an Interactive Phone Application in an Existing Enhanced Recovery ProgramSeamlessMD Podcast - Episode 39 - Rush Study Review: Value of an Interactive Phone Application in an Existing Enhanced Recovery Program
Digital Patient Podcast

SeamlessMD Podcast - Episode 39 - Rush Study Review: Value of an Interactive Phone Application in an Existing Enhanced Recovery Program

April 13, 2021
By
seamless

Subscribe on: RSS | SPOTIFY | APPLE PODCAST | GOOGLE | BREAKER | ANCHOR

Video:

In this episode of the SeamlessMD Podcast, Dr. Joshua Liu, CEO at SeamlessMD & Marketing colleague, Alan Sardana, review a manuscript from the Journal of Colorectal Disease, "Value of an Interactive Phone Application in an Existing Enhanced Recovery Program"*. See the full show notes below for details.

*Schlund, D., Poirier, J., Bhama, A.R. et al. Value of an interactive phone application in an established enhanced recovery program. Int J Colorectal Dis35, 1045–1048 (2020). https://doi.org/10.1007/s00384-020-03563-5

Guest(s): Dr. Joshua Liu (@joshuapliu), Co-founder & CEO at SeamlessMD

Episode 39 – Show notes:

[1:40] Introducing the manuscript, “Value of an Interactive Phone Application in an Established Enhanced Recovery Program” and its authors: Devan Schlund1, Jennifer Poirier2, Anuradha R Bhama3, Dana Hayden3, Theodore Saclarides3, Bruce Orkin4, Joanne Favuzza5.

[2:28] How SeamlessMD partneredwith Rush in late 2016 for their colorectal ERAS program and why the main goalof this study was to determine the impact of SeamlessMD on ERAS compliance &clinical outcomes (length of stay, readmissions, surgical site infections,total cost of care) since the Length of Stay improvements had plateaued for theERAS program;

[9:18] How participantsincluded all patients undergoing colorectal ERAS surgery between February 2017and July 2018, regardless of whether they opted into the phone application;

[9:40] How patients wouldreceive a patient education booklet provided by trained nurses during apre-operative clinical visit and how they would consent for SeamlessMDfollowing this clinic visit;

[11:10] How 289 patients wereenrolled in the study (147 patients with SeamlessMD and 142 without);

[12:11] How ERAS compliancewas measured for oral intake, solid food intake, % of patients completing bowelprep, and % of patients adhering to ERAS medication;

[12:20] Discussing ERAS Compliance Results:

Oral & solid food intake: No significant change between groups, however, patients with SeamlessMD were trending in the right direction;

Bowel prep completion: 74.8% of patients did bowel prep with SeamlessMD vs. 66.2% without (p=0.059);

ERAS medication adherence: 82.1% with SeamlessMD vs. 76.8% without (p=0.005);

[14:14] Why patientsmight be more compliant with ERAS protocols using digital patient engagement sincethe patient journey is complex and technology helps to distill information intobite-sized pieces and explains context for each protocol (e.g. why bowel prepis important for surgery);

[20:27] Discussing Clinical Outcomes Results:

Readmission rates: No significant variance between groups;

(There was no remotepatient monitoring enabled, which is a strong factor in influencing change inreadmission rates as seen by other SeamlessMD partners);

Surgical site infections (SSIs): 70% reduction in SSIs with SeamlessMD (p=0.019); (3.4% of patients had SSI with SeamlessMD vs. 11.3% had SSI without SeamlessMD);

Length of stay: 2.0 days reduction in mean length of stay with SeamlessMD (p=0.006); (4.4 days avg. with SeamlessMD vs. 6.4 days avg. without);

Total cost of care: $2,386 reduction in total cost of care with SeamlessMD (p=0.024);

($11,560 avg. cost withSeamlessMD vs. $13,946 avg. cost without);

[24:00] Why clinical outcomes may have improved with SeamlessMD because of increased patient compliance to ERAS elements such as the chlorhexidine wash before surgery which would have impacted SSI rates;

[29:09] Discussing the studylimitations:

1. Small sample size(only conducted at one medical institution);

2. Lack of randomization(due to opt-in nature of study);

3. Did not measurecompliance to all ERAS components;

4. (Not a studylimitation but a technological limitation) The group took a hands-off approach anddid not utilize SeamlessMD’s remote patient monitoring capabilities which mayhave reduced readmissions;

1 Department of General Surgery, Rush University Medical Center,
Chicago, IL, USA

2 Rush Alzheimer’s Disease Center, Rush University Medical Center,
Chicago, IL, USA

3 Department of General Surgery, Division ofColon and Rectal
Surgery, Rush University Medical Center, Chicago, IL, USA

4 Advent Health Center for Colon and RectalSurgery, University of
Central Florida, Orlando, FL, USA

5 Department of Surgery, Division of Colon andRectal Surgery,
Boston Medical Center, FGH Building 820 Harrison Avenue, Room
5008, Boston, MA 02118, USA


Share this post

Subscribe to SeamlessMD Blog

Subscribe Now

SeamlessMD Podcast - Episode 39 - Rush Study Review: Value of an Interactive Phone Application in an Existing Enhanced Recovery Program

Posted by:
seamless
on
April 13, 2021

Subscribe on: RSS | SPOTIFY | APPLE PODCAST | GOOGLE | BREAKER | ANCHOR

Video:

In this episode of the SeamlessMD Podcast, Dr. Joshua Liu, CEO at SeamlessMD & Marketing colleague, Alan Sardana, review a manuscript from the Journal of Colorectal Disease, "Value of an Interactive Phone Application in an Existing Enhanced Recovery Program"*. See the full show notes below for details.

*Schlund, D., Poirier, J., Bhama, A.R. et al. Value of an interactive phone application in an established enhanced recovery program. Int J Colorectal Dis35, 1045–1048 (2020). https://doi.org/10.1007/s00384-020-03563-5

Guest(s): Dr. Joshua Liu (@joshuapliu), Co-founder & CEO at SeamlessMD

Episode 39 – Show notes:

[1:40] Introducing the manuscript, “Value of an Interactive Phone Application in an Established Enhanced Recovery Program” and its authors: Devan Schlund1, Jennifer Poirier2, Anuradha R Bhama3, Dana Hayden3, Theodore Saclarides3, Bruce Orkin4, Joanne Favuzza5.

[2:28] How SeamlessMD partneredwith Rush in late 2016 for their colorectal ERAS program and why the main goalof this study was to determine the impact of SeamlessMD on ERAS compliance &clinical outcomes (length of stay, readmissions, surgical site infections,total cost of care) since the Length of Stay improvements had plateaued for theERAS program;

[9:18] How participantsincluded all patients undergoing colorectal ERAS surgery between February 2017and July 2018, regardless of whether they opted into the phone application;

[9:40] How patients wouldreceive a patient education booklet provided by trained nurses during apre-operative clinical visit and how they would consent for SeamlessMDfollowing this clinic visit;

[11:10] How 289 patients wereenrolled in the study (147 patients with SeamlessMD and 142 without);

[12:11] How ERAS compliancewas measured for oral intake, solid food intake, % of patients completing bowelprep, and % of patients adhering to ERAS medication;

[12:20] Discussing ERAS Compliance Results:

Oral & solid food intake: No significant change between groups, however, patients with SeamlessMD were trending in the right direction;

Bowel prep completion: 74.8% of patients did bowel prep with SeamlessMD vs. 66.2% without (p=0.059);

ERAS medication adherence: 82.1% with SeamlessMD vs. 76.8% without (p=0.005);

[14:14] Why patientsmight be more compliant with ERAS protocols using digital patient engagement sincethe patient journey is complex and technology helps to distill information intobite-sized pieces and explains context for each protocol (e.g. why bowel prepis important for surgery);

[20:27] Discussing Clinical Outcomes Results:

Readmission rates: No significant variance between groups;

(There was no remotepatient monitoring enabled, which is a strong factor in influencing change inreadmission rates as seen by other SeamlessMD partners);

Surgical site infections (SSIs): 70% reduction in SSIs with SeamlessMD (p=0.019); (3.4% of patients had SSI with SeamlessMD vs. 11.3% had SSI without SeamlessMD);

Length of stay: 2.0 days reduction in mean length of stay with SeamlessMD (p=0.006); (4.4 days avg. with SeamlessMD vs. 6.4 days avg. without);

Total cost of care: $2,386 reduction in total cost of care with SeamlessMD (p=0.024);

($11,560 avg. cost withSeamlessMD vs. $13,946 avg. cost without);

[24:00] Why clinical outcomes may have improved with SeamlessMD because of increased patient compliance to ERAS elements such as the chlorhexidine wash before surgery which would have impacted SSI rates;

[29:09] Discussing the studylimitations:

1. Small sample size(only conducted at one medical institution);

2. Lack of randomization(due to opt-in nature of study);

3. Did not measurecompliance to all ERAS components;

4. (Not a studylimitation but a technological limitation) The group took a hands-off approach anddid not utilize SeamlessMD’s remote patient monitoring capabilities which mayhave reduced readmissions;

1 Department of General Surgery, Rush University Medical Center,
Chicago, IL, USA

2 Rush Alzheimer’s Disease Center, Rush University Medical Center,
Chicago, IL, USA

3 Department of General Surgery, Division ofColon and Rectal
Surgery, Rush University Medical Center, Chicago, IL, USA

4 Advent Health Center for Colon and RectalSurgery, University of
Central Florida, Orlando, FL, USA

5 Department of Surgery, Division of Colon andRectal Surgery,
Boston Medical Center, FGH Building 820 Harrison Avenue, Room
5008, Boston, MA 02118, USA


Recent news from SeamlessMD

5 Big Takeaways from ERAS USA 2022
December 5, 2022

5 Big Takeaways from ERAS USA 2022

Learn More
TDP 83: U of Rochester Medical Center CMIO Dr. Gregg Nicandri: VR Training to Improve Surgical Quality, Eliminating the Mouse + Keyboard to Streamline Clinical Documentation, SDoH for Equitable Access to Care
November 30, 2022

TDP 83: U of Rochester Medical Center CMIO Dr. Gregg Nicandri: VR Training to Improve Surgical Quality, Eliminating the Mouse + Keyboard to Streamline Clinical Documentation, SDoH for Equitable Access to Care

Learn More
Improving health outcomes for patients living with interstitial lung disease and addressing the gaps in care is the aim of a new collaboration
November 29, 2022

Improving health outcomes for patients living with interstitial lung disease and addressing the gaps in care is the aim of a new collaboration

Learn More